National Journal of Pharmaceutical Sciences
  • Printed Journal
  • Refereed Journal
  • Peer Reviewed Journal

P-ISSN: 2788-9262, E-ISSN: 2788-9270

2024, Vol. 4, Issue 2, Part A


Sexually Transmitted Diseases (STDs): A critical public health concern


Author(s): Prajkta Sadanand Ingale

Abstract: A rise in the rates of sexually transmitted diseases, both worldwide and in Germany, has been observed especially among persons between the ages of 15 and 24 years. Since many infections are devoid of symptoms or cause few symptoms, the diseases are detected late, may spread unchecked, and be transmitted unwittingly. In the event of persistent infection, the effects depend on the pathogen in question. Manifestations vary widely, ranging from pelvic inflammatory disease, most often caused by Chlamydia trachomatis (in Germany nearly 30% of PID) or Neisseria gonorrhoeae (in Germany <2% of PID), to the development of genital warts or cervical dysplasia in cases of infection with the HP virus. Causal treatment does exist in most cases and should always be administered to the sexual partner(s) as well. An infection during pregnancy calls for an individual treatment approach, depending on the pathogen and the week of pregnancy.

Pages: 01-04 | Views: 81 | Downloads: 44

Download Full Article: Click Here

National Journal of Pharmaceutical Sciences
How to cite this article:
Prajkta Sadanand Ingale. Sexually Transmitted Diseases (STDs): A critical public health concern. Nat J Pharm Sci 2024;4(2):01-04.


National Journal of Pharmaceutical Sciences

National Journal of Pharmaceutical Sciences

National Journal of Pharmaceutical Sciences
Call for book chapter